Biology and significance of alpha‐fetoprotein in hepatocellular carcinoma

PR Galle, F Foerster, M Kudo, SL Chan… - Liver …, 2019‏ - Wiley Online Library
Hepatocellular carcinoma (HCC) is one of the most common causes of cancer‐related
deaths globally due, in part, to the majority of patients being diagnosed with intermediate or …

EASL clinical practice guidelines: management of hepatocellular carcinoma

PR Galle, A Forner, JM Llovet, V Mazzaferro… - Journal of …, 2018‏ - Elsevier
Liver cancer is the fifth most common cancer and the second most frequent cause of cancer-
related death globally. Hepatocellular carcinoma represents about 90% of primary liver …

The landscape of alpha fetoprotein in hepatocellular carcinoma: where are we?

X Hu, R Chen, Q Wei, X Xu - International journal of biological …, 2022‏ - pmc.ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the most common primary liver cancer and has been
acknowledged as a leading cause of death among cirrhosis patients. Difficulties in early …

Hepatocellular carcinoma review: current treatment, and evidence-based medicine

A Raza, GK Sood - World journal of gastroenterology: WJG, 2014‏ - pmc.ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the fifth most common tumor worldwide. Multiple
treatment options are available for HCC including curative resection, liver transplantation …

Aging of liver transplant registrants and recipients: trends and impact on waitlist outcomes, post-transplantation outcomes, and transplant-related survival benefit

F Su, L Yu, K Berry, IW Liou, CS Landis, SC Rayhill… - Gastroenterology, 2016‏ - Elsevier
Background & Aims Epidemiologic factors have generated increased demand for liver
transplantation among older patients. We aimed to describe trends in age among liver …

[HTML][HTML] A multistep, consensus-based approach to organ allocation in liver transplantation: toward a “blended principle model”

U Cillo, P Burra, V Mazzaferro, L Belli, AD Pinna… - American Journal of …, 2015‏ - Elsevier
Since Italian liver allocation policy was last revised (in 2012), relevant critical issues and
conceptual advances have emerged, calling for significant improvements. We report the …

[PDF][PDF] Excess mortality on the liver transplant waiting list: unintended policy consequences and Model for End‐Stage Liver Disease (MELD) inflation

PG Northup, NM Intagliata, NL Shah, SJ Pelletier… - …, 2015‏ - Wiley Online Library
The Model for End‐Stage Liver Disease (MELD) allocation system for liver transplantation
provides “exceptions” for diseases such as hepatocellular carcinoma (HCC). It was the aim …

Personalized treatment of patients with very early hepatocellular carcinoma

A Vitale, M Peck-Radosavljevic, EG Giannini… - Journal of …, 2017‏ - Elsevier
Hepatocellular carcinoma (HCC), in its very early stage, is heterogeneous both in terms of
liver function (ie, presence or absence of portal hypertension, model for end-stage liver …

Liver cirrhosis: evaluation, nutritional status, and prognosis

H Nishikawa, Y Osaki - Mediators of inflammation, 2015‏ - Wiley Online Library
The liver is the major organ for the metabolism of three major nutrients: protein, fat, and
carbohydrate. Chronic hepatitis C virus infection is the major cause of chronic liver disease …

Response to terlipressin and albumin is associated with improved liver transplant outcomes in patients with hepatorenal syndrome

S Piano, C Gambino, E Vettore, V Calvino… - …, 2021‏ - Wiley Online Library
Background and Aims Although terlipressin and albumin are effective at treating acute
kidney injury‐hepatorenal syndrome (AKI‐HRS), liver transplantation (LT) is the best …